Published in Nature · View the paper (DOI)
Researchers have successfully developed a new CRISPR system, Cas12a2, that can selectively kill cancer cells without harming healthy tissue. The technology uses a guide RNA to target specific genetic mutations and has shown promise in reducing tumor volume by 50% after a single treatment.
Coverage from 2 institutions